BULL CITY BIOBUCKS Join us for a fireside chat with Tavros Therapeutics who signed a $930M deal with Bayer in October 2022 on only $3M in equity financing. How the F$#% did they do that? Eoin McDonnell, CEO of Tavros, will breakdown the inner workings of engineering a successful major pharmaceutical partnership.
Track: Stage 1
Summit Celebration – BBQ, Brews and Live Music
In this session explore consumer focused scientific innovation in animal and human health, gaming, and e-commerce. FEATURED COMPANIESAja Labs, Osahon OjeagaAniluxx Biotechnology, Stefan C WeissJabin Beverage Co, Homayoon ErshadiMomtech, Hal EasonNyssa Care, Eden LaurinRarebird, Jeffrey DietrichWH Farms Co., Q. Nicole VanderhorstWisely, Rachelle McCray
Diagnostics, Tools + Platforms
In this session, explore new laboratory tools and therapeutic platform technology. FEATURED COMPANIESAltopa, Nicole WickerCoprata, Brian StonerGlycan Therapeutics, Jian LiuIntake Health, Michael BenderPhosphoGam, Dr. Richard LopezQatch Technologies, Zehra ParlakRedbud Labs, Richard SperoZymtronix, Stephane Corgie